logo
CRH plc (CRH): Among Stocks with Buy Ratings that Hedge Funds Love

CRH plc (CRH): Among Stocks with Buy Ratings that Hedge Funds Love

Yahoo08-04-2025

We recently published a list of . In this article, we are going to take a look at where CRH plc (NYSE:CRH) stands against other stocks with buy ratings that hedge funds love.
The U.S. stock market has been in chaos ever since President Trump announced his intent to increase tariffs on the U.S.'s trading partners. On April 2, 2025, the President officially presented the new tariff rates, calling them reciprocal tariffs. Since the presentation, the value of the U.S. stock market has started plunging. Though these tariffs have led to bloodbaths in many exchanges across the globe, the impact is heavy in the U.S. market where it originated.
China, one of the largest trading partners of the U.S., retaliated against the new tariff by slapping a 34% levy on U.S. goods, thus igniting a global trade war. The result? A $9 trillion wipeout in U.S. equity markets, according to CNBC. Experts are calling it the worst weekly performance since the COVID-19 crash.
READ ALSO: .
Retail investors are scrambling for the exits to protect their investments. However, hedge funds are quietly loading up on bargains. Analysts are perceiving an opportunity in the turmoil, and institutional investors are using the downturns to pepper their portfolios with high-conviction stocks at fire-sale prices. Right now, their buy lists are flashing green. They do not back the stocks unquestioningly, however, they look at the fundamentals, pricing power, and growth trends of the stocks to estimate their ability to outlast the storm.
If there is one thing we can learn from history, it is that markets often make their most significant rebounds after their steepest declines. When discussing the significance of virtues like patience and calmness in an investor during turmoil, a billionaire investor quoted a 19th-century poem: 'If you can keep your head when all about you are losing theirs… yours is the Earth and everything in it.' His point? Panic is expensive. On the other hand, opportunity can be priceless when accumulating institutional interest signals to investors where to look.
This brings us to the heart of our article today. Combining hedge fund filings, analyst upgrades, and real-time market data, we have uncovered 15 stocks with Buy ratings, which could potentially refine your portfolio. Top hedge funds are piling into these stocks, making them more appealing to investors interested in generating income.
But don't just take our word for it. History has given us a few examples to consider before making investment decisions. For instance, the 2020 pandemic crash is a prime example of how hedge fund portfolios can be better performers than the market index. Following the crash, hedge fund-backed stocks outperformed the market indexes by 14% in 2021. It indicates that institutional conviction can be louder than the market's noise.
We put together our list of 15 stocks by primarily considering the Buy ratings of the stocks. Our list included only those stocks with a strong Buy rating, as we see it as a crucial component for investors to make informed decisions. Another factor we considered was the hedge fund sentiment toward these stocks, according to Insider Monkey's Q4 2024 database. It indicated the level of institutional interest in the stock. The value of hedge funds has also been used to rank the stocks on our list, with the top stock having the highest value of hedge funds.
Additionally, we filtered our list by excluding stocks with negative earnings per share (EPS) over the past five years. We regarded those stocks with a positive EPS since it reflects consistency in profitability. All the data used in the article were taken from financial databases and analyst reports, with all information current as of April 5, 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A construction worker wearing a hard hat and safety glasses at a site, carrying concrete blocks.
One of the leading manufacturers and distributors of building materials, CRH plc (NYSE:CRH), operates in North America and Europe. The company is headquartered in Ireland and offers cement, aggregates, asphalt, and ready-mixed concrete to infrastructure, commercial, and residential construction markets. The company competes with competitors like Heidelberg Materials and Holcim for market share by gaining a competitive advantage through vertical integration and strategic acquisitions. CRH plc earned the position as an efficient supplier in the cyclical market by meeting the sustainability-driven demand for lower-carbon materials.
Attracting 90 hedge funds from the Insider Monkey Q4 2024 database, CRH plc (NYSE:CRH) has amassed $6.61 billion in investments. By the end of the financial year 2024, the company announced an industry-leading performance, with the revenue experiencing a 2% growth, reaching $35.6 billion. 40 value-accretive acquisitions in 2024 garnered an investment of $5 billion from the company. CRH reported that these acquisitions have been crucial to the company's growth as a market leader. They also announced a 6% increase in dividends per share, marking the 40th consecutive year of growth. For 2025, the company expects continued growth and value creation, attributed to the infrastructure activity in Europe and North America.
CRH plc (NYSE:CRH) leads in the construction materials sector, as reflected by its 18.51% EPS growth over five years despite strong competition prevailing in the market. Analysts' confidence in the company's market presence remains high, as represented by their Strong Buy rating.
Overall, CRH ranks 3rd on our list of stocks with buy ratings that hedge funds love. While we acknowledge the potential for CRH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than CRH but trades at less than 5 times its earnings, check out our report about this .
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Seeks $1B Latin America Exit: Sources
UnitedHealth Seeks $1B Latin America Exit: Sources

Yahoo

time19 minutes ago

  • Yahoo

UnitedHealth Seeks $1B Latin America Exit: Sources

UnitedHealth Group Incorporated (NYSE:UNH) is one of the best Dow stocks to invest in. The company is considering several offers for its Latin American business, according to two insiders familiar with the situation, as it works to recover from a series of major setbacks, including the removal of its CEO and a reported criminal accounting investigation. The largest US health insurer has aimed to exit Latin America since 2022, but selling its Banmedica unit has become more urgent recently due to multiple challenges, one source said. A senior healthcare professional giving advice to a patient in a clinic. New CEO Steve Hemsley told shareholders last week that he is focused on regaining their confidence following a disappointing earnings report and a Wall Street Journal story about a criminal probe into alleged Medicare fraud. UnitedHealth Group Incorporated (NYSE:UNH) maintains it has not been notified by the Department of Justice and stands by its business integrity. UnitedHealth Group Incorporated (NYSE:UNH) has received four non-binding bids for Banmedica, which operates in Colombia and Chile, totaling around $1 billion, according to sources who requested anonymity due to the confidential nature of the negotiations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Sign in to access your portfolio

Disney to Pay Comcast $438.7M for Full Hulu Ownership, Ending Valuation Dispute
Disney to Pay Comcast $438.7M for Full Hulu Ownership, Ending Valuation Dispute

Yahoo

time20 minutes ago

  • Yahoo

Disney to Pay Comcast $438.7M for Full Hulu Ownership, Ending Valuation Dispute

The Walt Disney Company (NYSE:DIS) is one of the best Dow stocks to invest in. The company has agreed to pay Comcast $438.7 million to buy out its remaining stake in the streaming service Hulu, ending a lengthy appraisal process. In 2023, The Walt Disney Company (NYSE:DIS) announced its plan to acquire Comcast's 33% share of Hulu, paying $8.6 billion based on a minimum value of $27.5 billion that the companies had agreed on in 2019. This move wasn't unexpected, as reports had indicated Disney's intention to gain full control of Hulu. The Walt Disney Company (NYSE:DIS) had originally acquired a two-thirds stake in Hulu through its purchase of Fox Corp.'s entertainment assets. After the initial payment, Disney and Comcast entered an appraisal process initially set to finish in 2024. The deal is expected to be finalized by July 24. Disney CEO Bob Iger made the following statement: 'We are pleased this is finally resolved. We have had a productive partnership with NBCUniversal, and we wish them the best of luck.' Meanwhile, The Walt Disney Company (NYSE:DIS) has started merging Hulu with its other streaming services, which are also bundled with ESPN+, its sports streaming platform. While we acknowledge the potential of DIS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.

Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030
Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030

Business Wire

time22 minutes ago

  • Business Wire

Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030

SAN MATEO, Calif.--(BUSINESS WIRE)-- Hercules Capital, Inc. (NYSE: HTGC) ('Hercules' or the 'Company'), today announced that it has priced an upsized underwritten public offering of $350.0 million in aggregate principal amount of 6.000% notes due June 2030 (the 'Notes'). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on June 16, 2025. The Notes are unsecured and bear interest at a rate of 6.000% per year, payable semiannually and will mature on June 16, 2030 and may be redeemed in whole or in part at any time or from time to time at the Company's option at par, plus a 'make whole' premium, if applicable. The Company expects to use the net proceeds from this offering to repay outstanding secured indebtedness under the Company's existing financing arrangements. Goldman Sachs & Co. LLC and SMBC Nikko Securities America, Inc. are acting as joint book-running managers of this offering. MUFG Securities Americas Inc., Zions Direct, Inc., RBC Capital Markets, LLC, Synovus Securities, Inc. and Keefe, Bruyette & Woods, A Stifel Company are acting as co-managers. The offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus. Copies of the preliminary prospectus supplement may be obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, New York 10282, or email: Prospectus-ny@ or telephone: 1-866-471-2526, or SMBC Nikko Securities America, Inc., 277 Park Avenue, New York, New York 10172, Attention: Debt Capital Markets – Transaction Management, or email: prospectus@ or telephone: 1-212-224-5135. Investors are advised to carefully consider the investment objectives, risks, charges and expenses of the Company before investing. The pricing term sheet dated June 11, 2025, the preliminary prospectus supplement dated June 11, 2025, and the accompanying prospectus dated December 11, 2024, each of which has been filed with the SEC, contain this and other information about the Company and should be read carefully before investing. The information in the pricing term sheet, the preliminary prospectus supplement, the accompanying prospectus and this press release is not complete and may be changed. The pricing term sheet, the preliminary prospectus supplement, the accompanying prospectus and this press release do not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Hercules Capital, Inc. Hercules Capital, Inc. (NYSE: HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology and life sciences industries. Since inception (December 2003), Hercules has committed more than $22 billion to over 680 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. Companies interested in learning more about financing opportunities should contact info@ or call (650) 289-3060. Hercules, through its wholly owned subsidiary business, Hercules Adviser LLC (the 'Adviser Subsidiary'), also maintains an asset management business through which it manages investments for external parties ('Adviser Funds'). The Adviser Subsidiary is registered as an investment adviser under the Investment Advisers Act of 1940. Hercules' common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol 'HTGC.' In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE: HCXY). Forward-Looking Statements This press release may contain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. We may use words such as 'anticipates,' 'believes,' 'expects,' 'intends,' 'will,' 'should,' 'may' and similar expressions to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and should not be relied upon in making any investment decision. Such statements are based on currently available operating, financial and competitive information and are subject to various risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations. While we cannot identify all such risks and uncertainties, we urge you to read the risks discussed in our Annual Report on Form 10-K and other materials that we publicly file with the Securities and Exchange Commission. Any forward-looking statements made in this press release are made only as of the date hereof. Hercules assumes no obligation to update any such statements in the future.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store